Cargando…
Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA
Autores principales: | Ponraj, Royston, Bryant, Adam, Dunlop, Lindsay, Range, Heather, Cobrador, Cherry, Ling, Silvia, Hsu, Danny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371986/ https://www.ncbi.nlm.nih.gov/pubmed/37495597 http://dx.doi.org/10.1038/s41408-023-00885-9 |
Ejemplares similares
-
P1344: METHODOLOGY OF AN INTERNATIONAL MULTI-CENTER RETROSPECTIVE REVIEW OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) BY THE TA-TMA WORKING GROUP
por: Ho, V., et al.
Publicado: (2022) -
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
por: Addad, Vanessa Vilani, et al.
Publicado: (2023) -
Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
por: Afrouzian, Marjan, et al.
Publicado: (2023) -
Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies
por: Font, Carme, et al.
Publicado: (2022) -
Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
por: Afrouzian, Marjan, et al.
Publicado: (2023)